_version_ 1783660549077204992
author Joshi, Maansi
Cook, Joselle
McCullough, Kristen
Nanaa, Ahmad
Gangat, Naseema
Foran, James M.
Murthy, Hemant S.
Kharfan-Dabaja, Mohamed A.
Sproat, Lisa
Palmer, Jeanne
Pardanani, Animesh
Tefferi, Ayalew
Begna, Kebede
Elliot, Michelle
Al-Kali, Aref
Patnaik, Mrinal
Shah, Mithun V.
Hogan, William J.
Litzow, Mark R.
Alkhateeb, Hassan B.
author_facet Joshi, Maansi
Cook, Joselle
McCullough, Kristen
Nanaa, Ahmad
Gangat, Naseema
Foran, James M.
Murthy, Hemant S.
Kharfan-Dabaja, Mohamed A.
Sproat, Lisa
Palmer, Jeanne
Pardanani, Animesh
Tefferi, Ayalew
Begna, Kebede
Elliot, Michelle
Al-Kali, Aref
Patnaik, Mrinal
Shah, Mithun V.
Hogan, William J.
Litzow, Mark R.
Alkhateeb, Hassan B.
author_sort Joshi, Maansi
collection PubMed
description
format Online
Article
Text
id pubmed-7933161
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-79331612021-03-19 Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation Joshi, Maansi Cook, Joselle McCullough, Kristen Nanaa, Ahmad Gangat, Naseema Foran, James M. Murthy, Hemant S. Kharfan-Dabaja, Mohamed A. Sproat, Lisa Palmer, Jeanne Pardanani, Animesh Tefferi, Ayalew Begna, Kebede Elliot, Michelle Al-Kali, Aref Patnaik, Mrinal Shah, Mithun V. Hogan, William J. Litzow, Mark R. Alkhateeb, Hassan B. Blood Cancer J Correspondence Nature Publishing Group UK 2021-03-04 /pmc/articles/PMC7933161/ /pubmed/33664234 http://dx.doi.org/10.1038/s41408-021-00437-z Text en © The Author(s) 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Correspondence
Joshi, Maansi
Cook, Joselle
McCullough, Kristen
Nanaa, Ahmad
Gangat, Naseema
Foran, James M.
Murthy, Hemant S.
Kharfan-Dabaja, Mohamed A.
Sproat, Lisa
Palmer, Jeanne
Pardanani, Animesh
Tefferi, Ayalew
Begna, Kebede
Elliot, Michelle
Al-Kali, Aref
Patnaik, Mrinal
Shah, Mithun V.
Hogan, William J.
Litzow, Mark R.
Alkhateeb, Hassan B.
Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
title Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
title_full Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
title_fullStr Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
title_full_unstemmed Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
title_short Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
title_sort salvage use of venetoclax-based therapy for relapsed aml post allogeneic hematopoietic cell transplantation
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933161/
https://www.ncbi.nlm.nih.gov/pubmed/33664234
http://dx.doi.org/10.1038/s41408-021-00437-z
work_keys_str_mv AT joshimaansi salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT cookjoselle salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT mcculloughkristen salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT nanaaahmad salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT gangatnaseema salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT foranjamesm salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT murthyhemants salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT kharfandabajamohameda salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT sproatlisa salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT palmerjeanne salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT pardananianimesh salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT tefferiayalew salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT begnakebede salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT elliotmichelle salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT alkaliaref salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT patnaikmrinal salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT shahmithunv salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT hoganwilliamj salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT litzowmarkr salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation
AT alkhateebhassanb salvageuseofvenetoclaxbasedtherapyforrelapsedamlpostallogeneichematopoieticcelltransplantation